The THOR Network Foundation, a U.S.-based 501(c)(3) non-profit organization, is an international multidisciplinary network of civilian and military providers committed to transforming the treatment of life-threatening bleeding to improve outcomes.
Our MISSION is to develop and implement best practices for life-threatening bleeding through education, training, research, and advocacy. THOR focuses on methods of improving the quality of therapeutics and blood products, indications for these agents, and implementation of best practices. THOR is leading the way internationally in revolutionizing transfusion strategies and resuscitation science.
Our impact has extended beyond trauma to include postpartum hemorrhage, surgical and gastrointestinal hemorrhage, and cancer-related bleeding. The urgency of THOR’s mission cannot be overstated. The mortality rate in children with traumatic injuries and severe bleeding ranges from 35–50%, and over a 10-year period there are approximately 300,000 deaths that are preventable with adequate care. The below statistics also emphasize the need for improving the care provided for those with life-threatening bleeding.
What Sets THOR Apart?
THOR’s Global Impact to Date
Broadening the Scope of THOR
For research projects that the THOR Network Foundation sponsors, the indirect cost rate policy is that it will provide a 25% indirect/overhead rate for all research projects that it sponsors. This rate includes all categories of sponsored projects and is consistent for all grantee organization types (Universities/Not for Profit/For Profit/Government).
With over 1000 members across 30 countries, The THOR Network’s ability to improve care, and change practice globally has been very successful. Training and education programs have been held in many countries across multiple continents that have led to a change in practice in the resuscitation of bleeding trauma patients. Research performed by THOR Network investigators to determine optimal resuscitation methods have been presented to the FDA which has resulted in increased availability of platelets.
THOR Network research has also led to changes in blood banking standards at hospitals that have expanded the use of blood products, to include whole blood in prehospital and in-hospital settings. Ongoing trials continue to determine if these changes definitively improve survival in patients with severe bleeding.
To donate to the THOR Foundation or to inquire about a project that you are interested in supporting please contact Dr. Philip C. Spinella at pspinella@thornetwork.com.
The THOR Network Foundation welcomes individual and corporate donations and grants.